Fundraising Fox

Brainbox Solutions

Houston, US · Founded 2018 · Delaware corporation · 5 known investors

BRAINBox Solutions develops a multi-modality diagnostic approach for mild traumatic brain injury (mTBI), combining blood biomarker panels with tablet-based neurocognitive testing to produce an objective injury score and a prognosis of post-injury symptoms. The tools are aimed at clinicians for diagnosing concussion and predicting patient outcomes.

AI & Machine LearningBiotechDigital HealthMedical Devices

Founders & leadership

SWSteve Wallace
Steve WallaceChief Operating Officer, Global Supply Chain Management
DJDonna J. Edmonds
Donna J. EdmondsinCEO
JVJames V. Snider
James V. SniderChief Technology Officer / Advisor
TVTim Van Meter
Tim Van MeterChief Scientific Officer
RN
Richard NoelChief Product and Commercial Officer
RS
Robert SleddNamed on SEC filing
SGScott Gazelle
Scott GazelleNamed on SEC filing
FPFrank Peacock
Frank PeacockPrincipal Investigator

Board

MGMarc Goldberg
Marc GoldberginBoard directorCo-Founder and Managing Partner at Bioventures Investors
DEDonna Edmonds
Donna EdmondsBoard directorAdvisory Board at Bioventures Investors
VCVikram Chaudhery
Vikram Chaudheryin𝕏Board directorPresident & COO at GENERAL INCEPTION

Investors · 5

Ambit Health VenturesBoston
Bioventures InvestorsWestborough · $15M – $100M
Genoa VenturesSan Francisco
VTC VenturesRoanoke · $100K – $5M
GENERAL INCEPTIONreportedPalo Altovia Vikram Chaudhery · board

Reported raises · per SEC filings

Form D private placements

$26M disclosed across 2 rounds · 2020–2023

▶$7.1MraisedNov 2023 · 32 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert SleddDirector
  • Donna EdmondsExecutive Officer, Director
  • Marc GoldbergExecutive Officer, Director
  • Scott GazelleDirector
  • Vikram ChaudheryDirector
Offering amount
$18.5M
Amount sold
$7.1M
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.9MraisedMar 2022 · 56 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert SleddDirector
  • Marc GoldbergDirector
  • Donna EdmondsExecutive Officer, Director
  • Steve WallaceExecutive Officer
  • Scott GazelleDirector
  • Vikram ChaudheryDirector
Offering amount
$28M
Amount sold
$18.9M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$471.8K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Brainbox Solutions do?
BRAINBox Solutions develops a multi-modality diagnostic approach for mild traumatic brain injury (mTBI), combining blood biomarker panels with tablet-based neurocognitive testing to produce an objective injury score and a prognosis of post-injury symptoms. The tools are aimed at clinicians for diagnosing concussion and predicting patient outcomes.
Who are Brainbox Solutions's investors?
Brainbox Solutions's investors include Ambit Health Ventures, Bioventures Investors, Genoa Ventures, VTC Ventures, GENERAL INCEPTION.
How much funding has Brainbox Solutions raised?
Brainbox Solutions has disclosed $26M raised across 2 rounds.
Where is Brainbox Solutions headquartered?
Brainbox Solutions is headquartered in Houston, US.